...
机译:FDA关于SSRI引起儿童自杀风险的咨询后,提供者联系的频率
Elaine H. Morrato, Dr.P.H.Anne M. Libby, Ph.D.Heather D. Orton, M.S.Frank V. deGruy III, M.D.David A. Brent, M.D.Richard Allen, M.S.Robert J. Valuck, Ph.D.Received Jan. 30, 2007, revisions received April 13, and May 8, 2007, accepted May 21, 2007 (doi: 10.1176/appi.ajp.2007.07010205). From the University of Colorado at Denver and Health Sciences Center, Denver, and the Western Psychiatric Institute and Clinics, University of Pittsburgh, Pittsburgh. Address correspondence and reprint requests to Dr. Valuck, University of Colorado, 4200 E. 9th Ave., Campus Box C238, Denver, CO 80262, robert.valuck@uchsc.edu (e-mail).Dr. Morrato, Dr. Libby, Ms. Orton, Mr. Allen, and Dr. Valuck report an unrestricted investigator-initiated research grant from Eli Lilly and Company. Dr. Valuck is an advisory board member for Eli Lilly and has received research support from Pfizer. Dr. Morrato has received research support from Janssen and Pfizer. Mr. Allen has received research support from GlaxoSmithKline. Dr. Brent and Dr. deGruy report no competing interests.Supported by an investigator-initiated grant from Eli Lilly and Company to fund the access fees to the independent PharMetrics database and salary support for the investigators. Eli Lilly did not provide data, was not involved in the original design of the study, and did not participate in the analysis of the data. Dr. Libby was also supported in part for this work by the W.T. Grant Foundation. Drs. Tamminga and Freedman reviewed the funding documents and the study and did not discern any evidence of bias from these funding sources.,;
机译:FDA关于SSRI引起的儿童自杀风险的咨询后,提供者联系的频率。
机译:相对于SSRI用户,SSRI-Statin用户有更少的精神病院接触,并且自杀行为的增加或全部导致死亡率
机译:FDA关于青少年自杀倾向的咨询之前和之后处方抗抑郁药的国家趋势
机译:使用基于GMM的情感声带反应的GMM频率内容来区分抑郁和自杀风险
机译:在州医疗计划中,对fda自杀性警告与抗癫痫药处方要求之间的关联进行评估时,采用三种统计估计程序进行评估。
机译:哥伦比亚自杀评估分类算法(C-CASA):FDA抗抑郁药的儿童自杀风险分析中的自杀事件分类
机译:PMH87在抗抑郁药处方中的发展趋势-FDA建议儿童和青少年之前有自杀倾向
机译:公众,FDa咨询委员会成员和FDa工作人员关于确定利益冲突程序和参与FDa咨询委员会资格的指南